These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1789 related items for PubMed ID: 8631191

  • 21. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
    Couzinet B, Young J, Kujas M, Meduri G, Brailly S, Thomas JL, Chanson P, Schaison G.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
    [Abstract] [Full Text] [Related]

  • 22. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 23. Effects of intermittent antiprogestin RU486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation.
    Kekkonen R, Croxatto HB, Lähteenmäki P, Salvatierra AM, Tuominen J.
    Hum Reprod; 1995 Feb; 10(2):287-92. PubMed ID: 7769050
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [Abstract] [Full Text] [Related]

  • 25. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
    Laumas V, Jain AK, Jha P, Rahman SA, Kumar D, Malik BK, Sarkar NN, Takkar D, Hingorani V, Laumas KR.
    Contraception; 1981 Feb; 23(2):211-25. PubMed ID: 6786828
    [Abstract] [Full Text] [Related]

  • 26. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H, Jung C, Taubert HD.
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [Abstract] [Full Text] [Related]

  • 27. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT.
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [Abstract] [Full Text] [Related]

  • 28. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
    London RS, Chapdelaine A, Upmalis D, Olson W, Smith J.
    Acta Obstet Gynecol Scand Suppl; 1992 Nov; 156():9-14. PubMed ID: 1324557
    [Abstract] [Full Text] [Related]

  • 29. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
    Sánchez-Criado JE, Galiot F, Bellido C, Gonzalez D, Tébar M.
    Biol Reprod; 1993 Apr; 48(4):916-25. PubMed ID: 8485257
    [Abstract] [Full Text] [Related]

  • 30. A possible dual mechanism of the anovulatory action of antiprogesterone RU486 in the rat.
    Sánchez-Criado JE, Bellido C, Galiot F, López FJ, Gaytán F.
    Biol Reprod; 1990 Apr; 42(5-6):877-86. PubMed ID: 2116924
    [Abstract] [Full Text] [Related]

  • 31. Influence of oral contraceptives on integrated secretion of gonadotropins.
    Dericks-Tan JS, Gudacker V, Taubert HD.
    Contraception; 1992 Oct; 46(4):369-77. PubMed ID: 1486775
    [Abstract] [Full Text] [Related]

  • 32. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 33. Opiatergic influence on gonadotropin-releasing hormone and luteinizing hormone release during the macaque menstrual cycle.
    Pau KY, Berria M, Hess DL, Spies HG.
    Biol Reprod; 1996 Aug; 55(2):478-84. PubMed ID: 8828858
    [Abstract] [Full Text] [Related]

  • 34. [Mechanism of LH release with synthetic LH-RH (author's transl)].
    Koyama T.
    Nihon Naibunpi Gakkai Zasshi; 1976 Sep 20; 52(9):881-97. PubMed ID: 828583
    [Abstract] [Full Text] [Related]

  • 35. Ovulation inhibition by daily i.m. administration of a highly active LH-RH analog (d-ser(TBU)6-LH-RH-(1-9)-nonapeptide-ethylamide).
    Baumann R, Kuhl H, Taubert HD, Sandow J.
    Contraception; 1980 Feb 20; 21(2):191-7. PubMed ID: 6768492
    [Abstract] [Full Text] [Related]

  • 36. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D, Steingold K, Cedars M, Lu JK, Meldrum DR, Judd HL, Chang RJ.
    J Clin Endocrinol Metab; 1989 Jun 20; 68(6):1111-7. PubMed ID: 2524501
    [Abstract] [Full Text] [Related]

  • 37. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL, Katz M.
    Contraception; 1979 Nov 20; 20(5):475-87. PubMed ID: 393456
    [Abstract] [Full Text] [Related]

  • 38. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R, Osman P, Dullaart J, de Greef WJ, Uilenbroek JT, de Jong FH.
    J Endocrinol; 1975 Jan 20; 64(1):37-47. PubMed ID: 1167896
    [Abstract] [Full Text] [Related]

  • 39. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI, Winter JS, Faiman C.
    Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
    Nillius SJ, Bergquist C, Wide L.
    Contraception; 1978 Jun 01; 17(6):537-45. PubMed ID: 352612
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 90.